Anemia and thrombocytopenia at chronic lymphocytic leukemia (CLL) presentation have long been considered to be predictive of a poor prognosis, irrespective of the cause of cytopenia, yielding an advanced stage of the disease. We identified 86 patients with CLL who were diagnosed after year 2000 with Binet C disease at first presentation. Cytopenia was considered related to autoimmune conditions in 27 (31.3%; stage C "immune") or secondary to bone marrow failure in 59 (68.6%; stage C "infiltrative"). No difference in clinical characteristics, mutational status, cytogenetics, TP53 and NOTCH1 mutations was observed between stage C "immune" and "infiltrative." Patients with stage C "immune" had a trend toward a better overall survival than patients with stage C " infiltrative" (median 74 vs. 63 months), but the difference was not statistically significant (p = 0.30). This difference was not modified by adjustment for CLL tumor burden at presentation, and survival of stage C "immune" patients was significantly inferior compared to an unselected cohort of patients with stage A, but similar to stage B. Our findings suggest that autoimmune cytopenias at CLL diagnosis have a negative impact on patient outcome.
Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era : is stage C always stage C? / C. Visco, A. Cortelezzi, F. Moretta, E. Falisi, F. Maura, S. Finotto, W. Barcellini, A. Ambrosetti, A. Neri, M. Ruggeri, F. Rodeghiero. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - 55:6(2014), pp. 1-5. [Epub ahead of print]
|Titolo:||Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era : is stage C always stage C?|
CORTELEZZI, AGOSTINO (Secondo)
|Settore Scientifico Disciplinare:||Settore MED/15 - Malattie del Sangue|
|Data di pubblicazione:||2014|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.3109/10428194.2013.834054|
|Appare nelle tipologie:||01 - Articolo su periodico|